|
1
|
Siegel RL, Miller KD and Jemal A: Cancer
statistics, 2016. CA Cancer J Clin. 66:7–30. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Rosell R and Karachaliou N: Lung cancer in
2014: Optimizing lung cancer treatment approaches. Nat Rev Clin
Oncol. 12:75–76. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Pérez-Soler R: Individualized therapy in
non-small-cell lung cancer: Future versus current clinical
practice. Oncogene. 28 Suppl 1:S38–S45. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Lin S and Gregory RI: MicroRNA biogenesis
pathways in cancer. Nat Rev Cancer. 15:321–333. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Cai Y, Yu X, Hu S and Yu J: A brief review
on the mechanisms of miRNA regulation. Genomics Proteomics
Bioinformatics. 7:147–154. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Ha M and Kim VN: Regulation of microRNA
biogenesis. Nat Rev Mol Cell Biol. 15:509–524. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Jansson MD and Lund AH: MicroRNA and
cancer. Mol Oncol. 6:590–610. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Reddy KB: MicroRNA (miRNA) in cancer.
Cancer Cell Int. 15:382015. View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Bartel DP: MicroRNAs: Target recognition
and regulatory functions. Cell. 136:215–233. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Kong YW, Ferland-McCollough D, Jackson TJ
and Bushell M: microRNA in cancer management. Lancet Oncol.
13:e249–e258. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Slack FJ and Weidhaas JB: MicroRNA in
cancer prognosis. N Engl J Med. 359:2720–2722. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Brannan CI, Dees EC, Ingram RS and
Tilghman SM: The product of the H19 gene may function as an RNA.
Mol Cell Biol. 10:28–36. 1990. View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Vennin C, Spruyt N, Dahmani F, Julien S,
Bertucci F, Finetti P, Chassat T, Bourette RP, Le Bourhis X and
Adriaenssens E: H19 non coding RNA-derived miR-675 enhances
tumorigenesis and metastasis of breast cancer cells by
downregulating c-Cbl and Cbl-b. Oncotarget. 6:29209–29223. 2015.
View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Zhou X, Yin C, Dang Y, Ye F and Zhang G:
Identification of the long non-coding RNA H19 in plasma as a novel
biomarker for diagnosis of gastric cancer. Sci Rep. 5:115162015.
View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Matouk IJ, Halle D, Gilon M and Hochberg
A: The non-coding RNAs of the H19-IGF2 imprinted loci: A focus on
biological roles and therapeutic potential in Lung Cancer. J Transl
Med. 13:1132015. View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Livak KJ and Schmittgen TD: Analysis of
relative gene expression data using real-time quantitative PCR and
the 2(-Delta Delta C(T)) method. Methods. 25:402–408. 2001.
View Article : Google Scholar : PubMed/NCBI
|
|
17
|
John B, Enright AJ, Aravin A, Tuschl T,
Sander C and Marks DS: Human MicroRNA targets. PLoS Biol.
2:e3632004. View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Krek A, Grün D, Poy MN, Wolf R, Rosenberg
L, Epstein EJ, MacMenamin P, da Piedade I, Gunsalus KC, Stoffel M
and Rajewsky N: Combinatorial microRNA target predictions. Nat
Genet. 37:495–500. 2005. View
Article : Google Scholar : PubMed/NCBI
|
|
19
|
Lewis BP, Shih IH, Jones-Rhoades MW,
Bartel DP and Burge CB: Prediction of mammalian microRNA targets.
Cell. 115:787–798. 2003. View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Hariharan M, Scaria V, Pillai B and
Brahmachari SK: Targets for human encoded microRNAs in HIV genes.
Biochem Biophys Res Commun. 337:1214–1218. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Grün D, Wang YL, Langenberger D, Gunsalus
KC and Rajewsky N: microRNA target predictions across seven
Drosophila species and comparison to mammalian targets. PLoS Comput
Biol. 1:e132005. View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Reid JG, Nagaraja AK, Lynn FC, Drabek RB,
Muzny DM, Shaw CA, Weiss MK, Naghavi AO, Khan M, Zhu H, et al:
Mouse let-7 miRNA populations exhibit RNA editing that is
constrained in the 5′-seed/cleavage/anchor regions and stabilize
predicted mmu-let-7a:mRNA duplexes. Genome Res. 18:1571–1581. 2008.
View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Chan WL, Huang HD and Chang JG: lncRNAMap:
A map of putative regulatory functions in the long non-coding
transcriptome. Comput Biol Chem. 50:41–49. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
24
|
Zhou W, Ye XL, Xu J, Cao MG, Fang ZY, Li
LY, Guan GH, Liu Q, Qian YH and Xie D: The lncRNA H19 mediates
breast cancer cell plasticity during EMT and MET plasticity by
differentially sponging miR-200b/c and let-7b. Sci Signal. 10:pii:
eaak9557. 2017. View Article : Google Scholar
|
|
25
|
Zhang Q, Li X, Li X, Li X and Chen Z:
LncRNA H19 promotes epithelial-mesenchymal transition (EMT) by
targeting miR-484 in human lung cancer cells. J Cell Biochem.
119:4447–4457. 2018. View Article : Google Scholar : PubMed/NCBI
|
|
26
|
Liang WC, Fu WM, Wong CW, Wang Y, Wang WM,
Hu GX, Zhang L, Xiao LJ, Wan DC, Zhang JF and Waye MM: The lncRNA
H19 promotes epithelial to mesenchymal transition by functioning as
miRNA sponges in colorectal cancer. Oncotarget. 6:22513–22525.
2015. View Article : Google Scholar : PubMed/NCBI
|
|
27
|
Lv M, Zhong Z, Huang M, Tian Q, Jiang R
and Chen J: lncRNA H19 regulates epithelial-mesenchymal transition
and metastasis of bladder cancer by miR-29b-3p as competing
endogenous RNA. Biochim Biophys Acta. 1864:1887–1899. 2017.
View Article : Google Scholar : PubMed/NCBI
|
|
28
|
Moes M, Le Béchec A, Crespo I, Laurini C,
Halavatyi A, Vetter G, Del Sol A and Friederich E: A novel network
integrating a miRNA-203/SNAI1 feedback loop which regulates
epithelial to mesenchymal transition. PLoS One. 7:e354402012.
View Article : Google Scholar : PubMed/NCBI
|
|
29
|
Shimoyama M, De Pons J, Hayman GT,
Laulederkind SJ, Liu W, Nigam R, Petri V, Smith JR, Tutaj M, Wang
SJ, et al: The Rat Genome Database 2015: Genomic, phenotypic and
environmental variations and disease. Nucleic Acids Res.
43:(Database Issue). D743–D750. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
30
|
Chang JT, Lee YM and Huang RS: The impact
of the Cancer Genome Atlas on lung cancer. Transl Res. 166:568–585.
2015. View Article : Google Scholar : PubMed/NCBI
|
|
31
|
Fatima R, Akhade VS, Pal D and Rao SM:
Long noncoding RNAs in development and cancer: Potential biomarkers
and therapeutic targets. Mol Cell Ther. 3:52015. View Article : Google Scholar : PubMed/NCBI
|
|
32
|
Gao Y, Gao F, Ma JL, Sun WZ and Song LP:
The potential clinical applications and prospects of microRNAs in
lung cancer. Onco Targets Ther. 7:901–906. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
33
|
Ricciuti B, Mecca C, Crinò L, Baglivo S,
Cenci M and Metro G: Non-coding RNAs in lung cancer. Oncoscience.
1:674–705. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
34
|
Sana J, Faltejskova P, Svoboda M and Slaby
O: Novel classes of non-coding RNAs and cancer. J Transl Med.
10:1032012. View Article : Google Scholar : PubMed/NCBI
|
|
35
|
Ariel I, Sughayer M, Fellig Y, Pizov G,
Ayesh S, Podeh D, Libdeh BA, Levy C, Birman T, Tykocinski ML, et
al: The imprinted H19 gene is a marker of early recurrence in human
bladder carcinoma. Mol Pathol. 53:320–323. 2000. View Article : Google Scholar : PubMed/NCBI
|
|
36
|
Li H, Yu B, Li J, Su L, Yan M, Zhu Z and
Liu B: Overexpression of lncRNA H19 enhances carcinogenesis and
metastasis of gastric cancer. Oncotarget. 5:2318–2329. 2014.
View Article : Google Scholar : PubMed/NCBI
|
|
37
|
Zhang L, Yang F, Yuan JH, Yuan SX, Zhou
WP, Huo XS, Xu D, Bi HS, Wang F and Sun SH: Epigenetic activation
of the MiR-200 family contributes to H19-mediated metastasis
suppression in hepatocellular carcinoma. Carcinogenesis.
34:577–586. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
38
|
Zhang E, Li W, Yin D, De W, Zhu L, Sun S
and Han L: c-Myc-regulated long non-coding RNA H19 indicates a poor
prognosis and affects cell proliferation in non-small-cell lung
cancer. Tumour Biol. 37:4007–4015. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
39
|
Cui JD, Mo J, Luo M, Yu Q, Zhou S, Li T,
Zhang Y and Luo W: c-Myc-activated long non-coding RNA H19
downregulates miR-107 and promotes cell cycle progression of
non-small cell lung cancer. Int J Clin Exp Pathol. 8:12400–12409.
2015.PubMed/NCBI
|
|
40
|
Matouk IJ, DeGroot N, Mezan S, Ayesh S,
Abu-lail R, Hochberg A and Galun E: The H19 non-coding RNA is
essential for human tumor growth. PLoS One. 2:e8452007. View Article : Google Scholar : PubMed/NCBI
|
|
41
|
Lin CW, Lin PY and Yang PC: Noncoding RNAs
in tumor epithelial-to-mesenchymal transition. Stem Cells Int.
2016:27327052016. View Article : Google Scholar : PubMed/NCBI
|
|
42
|
Heerboth S, Housman G, Leary M, Longacre
M, Byler S, Lapinska K, Willbanks A and Sarkar S: EMT and tumor
metastasis. Clin Transl Med. 4:62015. View Article : Google Scholar : PubMed/NCBI
|
|
43
|
Jin J, Deng J, Wang F, Xia X, Qiu T, Lu W,
Li X, Zhang H, Gu X, Liu Y, et al: The expression and function of
microRNA-203 in lung cancer. Tumour Biol. 34:349–357. 2013.
View Article : Google Scholar : PubMed/NCBI
|
|
44
|
Tang R, Zhong T, Dang Y, Zhang X, Li P and
Chen G: Association between downexpression of MiR-203 and poor
prognosis in non-small cell lung cancer patients. Clin Transl
Oncol. 18:360–368. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
45
|
Funamizu N, Lacy CR, Kamada M, Yanaga K
and Manome Y: MicroRNA-203 induces apoptosis by upregulating Puma
expression in colon and lung cancer cells. Int J Oncol.
47:1981–1986. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
46
|
Ding X, Park SI, McCauley LK and Wang CY:
Signaling between transforming growth factor β (TGF-β) and
transcription factor SNAI2 represses expression of microRNA miR-203
to promote epithelial-mesenchymal transition and tumor metastasis.
J Biol Chem. 288:10241–10253. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
47
|
Zhou X, Ye F, Yin C, Zhuang Y, Yue G and
Zhang G: The interaction between MiR-141 and lncRNA-H19 in
regulating cell proliferation and migration in gastric cancer. Cell
Physiol Biochem. 36:1440–1452. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
48
|
Zhu M, Chen Q, Liu X, Sun Q, Zhao X, Deng
R, Wang Y, Huang J, Xu M, Yan J and Yu J: lncRNA H19/miR-675 axis
represses prostate cancer metastasis by targeting TGFBI. FEBS J.
281:3766–3775. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
49
|
Zhuang M, Gao W, Xu J, Wang P and Shu Y:
The long non-coding RNA H19-derived miR-675 modulates human gastric
cancer cell proliferation by targeting tumor suppressor RUNX1.
Biochem Biophys Res Commun. 448:315–322. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
50
|
Shi Y, Wang Y, Luan W, Wang P, Tao T,
Zhang J, Qian J, Liu N and You Y: Long non-coding RNA H19 promotes
glioma cell invasion by deriving miR-675. PLoS One. 9:e862952014.
View Article : Google Scholar : PubMed/NCBI
|
|
51
|
Imig J, Brunschweiger A, Brümmer A,
Guennewig B, Mittal N, Kishore S, Tsikrika P, Gerber AP, Zavolan M
and Hall J: miR-CLIP capture of a miRNA targetome uncovers a
lincRNA H19-miR-106a interaction. Nat Chem Biol. 11:107–114. 2015.
View Article : Google Scholar : PubMed/NCBI
|
|
52
|
Cai X and Cullen BR: The imprinted H19
noncoding RNA is a primary microRNA precursor. RNA. 13:313–316.
2007. View Article : Google Scholar : PubMed/NCBI
|
